- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05102955
Turkish Validity and Reliability of the Visual Function Classification System (VFCS)
April 6, 2022 updated by: Hatice Adiguzel, Kahramanmaras Sutcu Imam University
Turkish Validity and Reliability of the Visual Function Classification System (VFCS) in Children With Cerebral Palsy (CP)
Cerebral Palsy (CP) is the most common childhood disorder that occurs with a lesion in the developing infant brain, seen in 2-3/1000 live births.
CP is a posture, movement and tone disorder that occurs due to prenatal or postnatal causes.
It is not progressive, but since the anatomy of the lesion and the physical development of the individual are not completed, the course of the disorder may vary throughout life.
Accompanied by motor dysfunctions, it varies according to clinical types.
In addition to this, various visual, sensory and behavioral problems, speech disorders that cause learning difficulties and cognitive problems can also be observed.
Ophthalmic disorders are the most common problem in CP and can also affect the developmental process of the patient.
Since ophthalmic disorders and neurological deficits are associated in CP, the relationship between neurological disorder and ophthalmic disorders has been investigated in the literature.
The aim of this study is to establish the Turkish validity and reliability of the Visual Function Classification System (VFCS) specific to individuals with Cerebral Palsy (CP).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Cerebral Palsy (CP) is the most common childhood disorder that occurs with a lesion in the developing infant brain, seen in 2-3/1000 live births.
CP is a posture, movement and tone disorder that occurs due to prenatal or postnatal causes.
It is not progressive, but since the anatomy of the lesion and the physical development of the individual are not completed, the course of the disorder may vary throughout life.
Accompanied by motor dysfunctions, it varies according to clinical types.
In addition to this, various visual, sensory and behavioral problems, speech disorders that cause learning difficulties and cognitive problems can also be observed.
Ophthalmic disorders are the most common problem in CP and can also affect the developmental process of the patient.
Since ophthalmic disorders and neurological deficits are associated in CP, the relationship between neurological disorder and ophthalmic disorders has been investigated in the literature.
Studies show that 60-70% of children with CP also have CVI.
CVI is defined as a lack of visual function resulting from damage or disruption of the retrogeniculate visual pathways (optic radiations, occipital cortex, visual associative areas) in the absence of any major ocular disease.
This involvement of the retrogeniculate visual pathways is common in CP, given that the lesions most commonly underlying this condition also affect the visual areas of the brain.
CVI is defined as bilateral loss of central visual function (visual acuity) caused by neurological damage to the visual cortex and⁄or visual pathway structures.
It is most commonly caused by hypoxic ischemia causing periventricular leukomalacia (PVL) in the preterm infant.
Disturbance of the oculomotor system is also typical in CP.
Abnormalities in functions such as fixation, tracking and saccadic movements; Strabismus and abnormal ocular movements are also frequently described.
With the participation of visual relational areas, visual perception and integration disorders, which are often seen as visual cognitive disorders, can occur when the child reaches school age.
These impairments should be investigated even when visual functions such as visual acuity and visual field are normal or mildly impaired.Gross Motor Classification System (GMFCS) and Manual Skill Classification System (MACS) are used by clinicians to obtain a clear picture of how motor skills of individuals with CP, mobility levels in daily life and independence levels of hand functions are affected.
However, although it is known that children with CP have visual effects, the methods in which visual functions are classified are insufficient.
Therefore, Baranello et al.
A tool has been developed to classify the visual function classification system.
The aim of this study is to establish the Turkish validity and reliability of the Visual Function Classification System (VFCS) specific to individuals with Cerebral Palsy (CP).
Study Type
Observational
Enrollment (Actual)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dulkadiroglu
-
Kahramanmaras, Dulkadiroglu, Turkey, 46100
- Hatice Adıgüzel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Children with CP of different clinical types in the 1-18 age range
Description
Inclusion Criteria:
-Children with CP diagnosed with CP between the ages of 1-18 with visual perception problems and visual impairments
Exclusion Criteria:
- Individuals with CP whose parents did not sign the voluntary consent form
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1/Observational Questionnaires
All one Group/ Visual Function Classification System(VFCS), Gross Motor Function Classification System (GMFCS), Manual Ability Classification System (MACS), Communication Function Classification System(CFCS) Questionnaires will be assessed by the different raters(physiotherapists).
But Visual Function Classification System(VFCS) will be assesed also by the parents.
|
All one Group/ Visual Function Classification System(VFCS), Gross Motor Function Classification System (GMFCS), Manual Ability Classification System (MACS), Communication Function Classification System(CFCS) Questionnaires will be assessed by the different raters (physiotherapists).
But Visual Function Classification System(VFCS) will be assesed also by the parents.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Function Classification System (VFCS)
Time Frame: The same physiotherapists and parents (P) of children with CP will re-apply the VFCS classifications to individuals with CP up to 15-day after the first assessment.
|
The VFCS was developed empirically following a step-by step process to classify visual abilities of children with CP in everyday life.
VFCS levels will be scored as; LEVEL I: Uses visual function easily and successfully in vision-related activities.
LEVEL II: Uses visual function successfully but needs self-initiated compensatory strategies.
LEVEL III: Uses visual function but needs some adaptations.
LEVEL IV: Uses visual function in very adapted environments but performs just part of vision-related activities.
LEVEL V: Does not use visual function even in very adapted environments.The same TWO physiotherapists and parents (M) of children with CP will re-apply the VFCS classifications to individuals with CP at 15-day intervals.
|
The same physiotherapists and parents (P) of children with CP will re-apply the VFCS classifications to individuals with CP up to 15-day after the first assessment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gross Motor Function Classification System (GMFCS)
Time Frame: Day 1
|
Gross Motor Function Classification System (GMFCS), which defines both disease severity and disease course, is used to classify motor impairment in children with cerebral palsy.
This system is a system that is used to inform the family about the instant performance of the child.
Gross Motor Function Classification System is a valid and reliable standardized system that classifies the gross motor functions of children with CP between the ages of 0-12 at five levels.
Children with cerebral palsy are least dependent at level 1 and most dependent at level 5 in motor functions.
|
Day 1
|
|
Manual Ability Classification System (MACS)
Time Frame: Day 1
|
MACS determines how children with CP use their hands while holding objects in daily activities.
MACS; defines five levels.
The determination of levels is based on the child's ability to hold objects to himself and the need for assistance and adaptation in performing manual activities in daily life.
MACS aims to categorize what a child does in general, not how well he performs during a specific test.
MACS assesses the usual general ability to hold objects, not the function of the two hands separately or their ability to grasp.
Instead of considering the difference in function between the two hands, MACS considers how the child handles objects appropriate for his age.
MACS can be used for children aged 4-18.
Levels I, II, III include children with minor limitations, while children with severe functional limitations will usually be found at levels IV and V.
|
Day 1
|
|
Communication Function Classification System (CFCS)
Time Frame: Day 1
|
The CFCS assesses the communication functions of an individual with CP in daily life on a five-level scale.
The differences between the five levels of the CFCS are based on important aspects of functional communication, namely the performance of the sender and receiver roles, the speed of the conversation, and the communication partner type.
Turkish validity and reliability were established.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: hatice Adiguzel, PhD, Kahramanmaraş Sütçü İmam University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2021
Primary Completion (Actual)
February 15, 2022
Study Completion (Actual)
March 15, 2022
Study Registration Dates
First Submitted
October 15, 2021
First Submitted That Met QC Criteria
November 1, 2021
First Posted (Actual)
November 2, 2021
Study Record Updates
Last Update Posted (Actual)
April 7, 2022
Last Update Submitted That Met QC Criteria
April 6, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- haticeadiguzel
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesRecruiting
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
Cairo UniversityCompletedCerebral Palsy (CP) | Unilateral Cerebral PalsyEgypt
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
IRCCS Fondazione Stella MarisNot yet recruitingCerebral Palsy (CP) | EEG | Unilateral Cerebral Palsy | Action ObservationItaly
-
IRCCS Fondazione Stella MarisUniversity of Siena, ItalyRecruitingCerebral Palsy (CP) | Motor Imagery | CP (Cerebral Palsy) | Action ObservationItaly
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
Clinical Trials on Observational questionnaires
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)CompletedAcute Myeloid Leukemia (AML)United States
-
Universiteit AntwerpenEnd-of-Life Research GroupCompletedSuspected Lung CancerBelgium
-
Shanghai Children's Medical CenterCompletedSymptom Spectrum and Risk Factors for FeverChina
-
Laval UniversityCISSS de Chaudière-Appalaches; VITAM: Research Center on Sustainable Health; Centre... and other collaboratorsRecruiting
-
Vanderbilt University Medical CenterRecruitingQuality of Life | Parkinson Disease | Essential Tremor | Tremor | RadiosurgeryUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University Hospital, ToulouseNot yet recruiting
-
Massachusetts General HospitalRecruiting
-
Taysha Gene Therapies, Inc.Withdrawn
-
University Hospital, AntwerpUniversiteit AntwerpenUnknownType 1 Diabetes | Diastolic Dysfunction | Coronary Artery CalcificationsBelgium